The U.S. Ambassador Joseph Cella hosted Pacific health officials and clinicians for a dialogue on the prevention, diagnosis, and treatment of kidney disease. The conversation generated ideas and inspiration for new ways that the United States, Fiji, and other Pacific island countries can work together to overcome health challenges.
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients.
The award will support them as they work full-time on a solution for safer at-home dialysis—an issue they'll meet with greater urgency as the coronavirus pandemic makes in-person treatment riskier
A major award could provide new hope to thousands of kidney patients in the U.S., and possibly, freedom from undergoing traditional dialysis.
The Center for Dialysis Innovation earns acclaim for a porous synthetic graft intended to make the blood-cleansing process safer and more reliable.
Today, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced the six winners of the $3 million KidneyX: Redesign Dialysis Phase 2 competition during the virtual KidneyX Summit. Each recipient will receive $500,000, recognizing the transformative work and creativity these innovators have brought to reimagining dialysis care.
A $500,000 KidneyX prize has been awarded to The Kidney Project — a collaboration between Vanderbilt University Medical Center (VUMC) and UC San Francisco (UCSF) — for the development of an implantable dialysis system that would enable patients to safely and effectively treat kidney failure at home.
During the virtual KidneyX Summit, the HHS and the American Society of Nephrology announced the six winners of phase 2 of the Redesign Dialysis competition, which was launched in November 2019.
25 People Win the KidneyX Patient Innovator Challenge with Ideas to Improve Patients Lives
After decades of slow progress, researchers are exploring better treatments for kidney failure — which kills more people than HIV or tuberculosis.
